House Bill 5575 - Safe Medicine Act

Purpose and Summary

Chamber: House

Introduced date: 2023-09-19

Recent Activity

Referred to the Subcommittee on Health.

Alternative Names

Safe Medicine Act

Safe Medicine Act

To direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over-dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination, and for other purposes.

Associated Legislation

undefined

Policy Areas

Health

Potential Impact

Cardiovascular and respiratory health

Chemical and biological weapons

Drug safety, medical device, and laboratory regulation

Drug therapy

Emergency medical services and trauma care

Health technology, devices, supplies

Infectious and parasitic diseases

Manufacturing

Medical tests and diagnostic methods

Military medicine

Military procurement, research, weapons development

Nuclear weapons

Public contracts and procurement

Strategic materials and reserves

Trade agreements and negotiations

Veterans' medical care

Worker safety and health

Sponsors and Supporters

Rep. Posey, Bill [R-FL-8]

Cosponsors and Supporters

undefined

Committees and Subcommittees

Veterans' Affairs Committee

Health Subcommittee

Energy and Commerce Committee

Health Subcommittee

Ways and Means Committee

Armed Services Committee

Variations and Revisions

Safe Medicine Act

2/5/2024, 2:30 PM

Safe Medicine Act

This bill addresses issues related to the manufacture of drugs, including essential medicines.

The Department of Health and Human Services, the Department of Defense, and the Department of Veterans...

Congress
118

Number
HR - 5575

Introduced on
2023-09-19

# Amendments
0

Sponsors
+5

Variations and Revisions

9/19/2023

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Safe Medicine Act

This bill addresses issues related to the manufacture of drugs, including essential medicines.

The Department of Health and Human Services, the Department of Defense, and the Department of Veterans...

Alternative Names
Official Title as IntroducedTo direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over-dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination, and for other purposes.

Policy Areas
Health

Potential Impact
Cardiovascular and respiratory health•
Chemical and biological weapons•
Drug safety, medical device, and laboratory regulation•
Drug therapy•
Emergency medical services and trauma care•
Health technology, devices, supplies•
Infectious and parasitic diseases•
Manufacturing•
Medical tests and diagnostic methods•
Military medicine•
Military procurement, research, weapons development•
Nuclear weapons•
Public contracts and procurement•
Strategic materials and reserves•
Trade agreements and negotiations•
Veterans' medical care•
Worker safety and health

Comments

Recent Activity

Latest Summary10/20/2023

Safe Medicine Act

This bill addresses issues related to the manufacture of drugs, including essential medicines.

The Department of Health and Human Services, the Department of Defense, and the Department of Veterans...


Latest Action9/28/2023
Referred to the Subcommittee on Health.